EM-T3Expert Opinion on Drug Safety2025-06-12第 25 卷第 10 期，1965-1972
Constipation-predominant irritable bowel syndrome treatment options Linaclotide, Lubiprostone, Plecanatide, and Tenapanor: analysis of the FDA Adverse Event Reporting System (FAERS) database
